New results of a global study of 500 patients show that a daily pill can double survival rates. “This study compared this ...

The study showed that an experimental pill from the company Revolution Medicines almost doubled metastatic pancreatic cancer patients’ survival times compared with chemotherapy.

The experimental drug daraxonrasib, which doubled survival time in patients with advanced pancreatic cancer, may also prove effective for lung, colon and ovarian cancers.

The act of breathing the Arizona air creates the risk for a deadly disease called valley fever. Here are 9 things Arizonans ...

A novel pill helped people with advanced pancreatic cancer live longer, researchers reported Sunday, raising hopes of ...

Imagine a future where cancer treatment affects only the tumor, where eye injections are no longer required and brain ...

A new drug for advanced pancreatic cancer is being hailed as a major breakthrough after trial results showed that it almost ...

A Phoenix federal judge on June 1 gave a New River couple multi-year prison sentences for deliberately defrauding Arizona's ...

Washington will almost certainly try to claim credit for the decline in overdose deaths. But the evidence suggests multiple ...

(Corrects paragraph 5 to say "doubled" not "reduced") By Julie Steenhuysen CHICAGO, May 31 (Reuters) - Revolution Medicine's ...

For decades, the molecular switch that drives most pancreatic cancers was ‘undruggable’. No longer. A new drug has now nearly doubled how long patients live.